β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma. [electronic resource]
Producer: 20210402Description: 195-209 p. digitalISSN:- 2515-4184
- Animals
- Binding Sites
- Bridged Bicyclo Compounds, Heterocyclic -- administration & dosage
- CREB-Binding Protein -- metabolism
- Carcinoma, Squamous Cell -- drug therapy
- Cell Line, Tumor
- ErbB Receptors -- chemistry
- Fucose -- metabolism
- Fucosyltransferases -- genetics
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Mice
- Models, Molecular
- Mouth Neoplasms -- drug therapy
- Neoplasm Metastasis
- Polysaccharides -- metabolism
- Protein Structure, Tertiary
- Pyrimidinones -- administration & dosage
- Small Molecule Libraries -- administration & dosage
- Wnt Signaling Pathway -- drug effects
- Xenograft Model Antitumor Assays
- beta Catenin -- metabolism
- Galactoside 2-alpha-L-fucosyltransferase
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.